Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta. Roulot, Dominique; Brichler, Ségolène; Layese, Richard; BenAbdesselam, Zahia; Zoulim, Fabien; Thibault, Vincent; Scholtes, Caroline; Roche, Bruno; Castelnau, Corinne; Poynard, Thierry; Chazouillères, Olivier; Ganne, Nathalie; Fontaine, Hélène; Gournay, Jerome; Guyader, Dominique; Le Gal, Frédéric; Nahon, Pierre; Roudot-Thoraval, Françoise; Gordien, Emmanuel; Deltavir study group. Journal of Hepatology. 2020; 73: p.1046-1062. doi:10.1016/j.jhep.2020.06.038
Article